Hypersomnia Research, Studies, and Clinical Trials

Treatment of Narcolepsy

Patients are needed to participate in a clinical research study evaluating JZP-110 for the treatment of narcolepsy. This trial is a 12-week, randomized, double-blind, placebo-controlled, multicenter, 4-treatment parallel group study of the safety and efficacy of JZP-110 in the treatment of excessive sleepiness in adults with narcolepsy. There are 54 site locations for this study, including in the US, Canada, and France. For those who qualify and have an interest in participating, but a study site is not nearby, all travel and accommodation arrangements to a study site will be covered by the study.

To learn more about this study, review the eligibility requirements, or to find a participating location and doctor, go here.

Evaluating Brain Imaging Results

Trotti's Study

If you have been diagnosed with Idiopathic Hypersomnia and would like to participate, please contact Dr. Lynn Marie Trotti for more information at 404-712-7240 or emorysleepresearch@gmail.com

Xyrem Study

Have you taken Xyrem within the past two years? Harvard Medical School and Brigham and Women’s Hospital is currently conducting interviews to determine how FDA-mandated safety programs impact the prescribing and use of drugs like Xyrem.  

Little is known about the impact of such programs on physicians, patients, and manufacturers, including whether they increase prescribing burdens, reduce patient access, enhance costs, or improve patients’ experiences with their illnesses. This study will seek to answer these questions. Participation will involve a 60-minute interview. Upon successful conclusion of the interview, study participants will receive a $50 Amazon gift card. 

If you have received Xyrem within the past two years, you may be eligible. For more information, please contact the study principal investigator, Dr. Ameet Sarpatwari at asarpatwari@partners.org

Clinical Research in Primary Hypersomnias

We are evaluating the safety and efficacy of an investigational drug product to address symptoms experienced by subjects with sleep disorders such as Idiopathic Hypersomnia and Narcolepsy without cataplexy. 

  • Recruiting patients diagnosed with Narcolepsy without Cataplexy
  • 18 or older
  • Information on date of diagnosis and place of diagnosis
  • Have your MSLT results available when calling

Contact:

Jasper L. Barnes MPA

Clinical Research Coordinator

Emory Sleep Center

 

New Rules to Open up Data from Clinical Trials soon go into effect! Read the article here.